ALYSSA CAPAWANA: Open Payments
NPI 1093331787 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$599 in 32 payments from 5 companies in 2025. Trend: 2023 $649 · 2024 $853 · 2025 $599
Food & beverage: $599
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 13 | $266 |
| ABBVIE INC. | 14 | $196 |
| REVANCE THERAPEUTICS, INC. | 3 | $101 |
| Lilly USA, LLC | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
Products named: DAXI, NEMLUVIO, EBGLYSS, NUZYRA.
Industry payments across FL — which companies pay providers there.
